Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis (NCT05844865)
🩺 Plain-English Summary (8th-Grade Level)
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
Who can join: Review the eligibility criteria below.
Location: Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
Age range: 18 Years
🧪 Interventions in This Study
- Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
📞 Contact the Study Coordinator
Phone: (877) 827-7883
Email: ucstudy@uci.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peritoneal Carcinomatosis
- Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms — Montreal, Quebec
- Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors — Tampa, Florida
- Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC — Lexington, Kentucky
- A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery — Tampa, Florida
- Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) — Montreal, Quebec
Explore by condition: All Peritoneal Carcinomatosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.